DURHAM, N.C., Dec. 3, 2010 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) (SIX Swiss Exchange: OXBT) today announced that the Company plans to report second quarter fiscal year 2011 financial results on Thursday, December 9, 2010. Oxygen’s Chairman and CEO Chris Stern, and Chief Financial Officer Michael Jebsen, will host a conference call and live webcast to discuss the results on Friday, December 10, 2010 at 11 a.m. EST.
To access the live teleconference dial (866) 825-3209 (U.S. and Canada) or (617) 213-8061 (international.) The participant passcode is 81091554. A live webcast will be available on our web site http://www.oxybiomed.com/investors.htm.
A replay of the webcast will be available on the Oxygen website, or by phone for a limited time. To access the replay by phone, call (888) 286-8010 (U.S. and Canada) or (617) 801-6888 (international) for a limited time. The passcode for the replay is 25705024.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte that is being formulated for both intravenous and topical delivery. This year, the company launched its DERMACYTE® line of oxygen-rich skin care products. In addition, the company is focused on perfluorocarbon-based oxygen carriers for use in traumatic brain injury, decompression sickness, personal care, and topical wound healing.
Ellen Corliss | |
Oxygen Biotherapeutics, Inc. | |
Vice President, | |
Investor Relations & Corporate Communications | |
(919) 855-2112 | |
SOURCE Oxygen Biotherapeutics, Inc.
